Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step chiral synthesis of PE phospholipid intermediate. High yield, mild conditions, scalable process for drug delivery systems.
Novel biocatalytic route for L-carnitine production offers >99% ee, reduced toxicity, and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN111778229B reveals high-efficiency hydrolase mutants for >99% ee production. Ideal for reliable pharma intermediate supply chains.
Patent CN105063162A reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability in pharmaceutical manufacturing processes.
Patent CN114835541A details a Pd-catalyzed method for high-yield chiral allenoic acids. Offers superior atom economy and scalability for pharmaceutical intermediate manufacturing.
Novel synthesis of (R)-p-hydroxyphenylglycine via phenol condensation offers high yield and purity for beta-lactam antibiotic manufacturing, ensuring robust supply chain continuity.
Patent CN101659623A details a novel chemical resolution for leucine and isoleucine using DBTA, offering high purity and recyclable agents for reliable supply chains.
Patent CN105384608A details a novel route for isopropyl-phenol derivatives. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity intermediates.
Discover the patented synthesis of (2S)-indoline-2-carboxylic acid. A reliable pharmaceutical intermediates supplier offering cost reduction in API manufacturing via novel resolution.
Patent CN107759466B details a water-based chiral resolution for S-(+)-Ketoprofen. Achieve high purity with reduced resolving agent costs and green manufacturing.
Discover a novel synthetic route for Tapentadol Hydrochloride offering mild conditions and high purity. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN107540601B details a cost-effective route for Avibactam intermediates using Pidolidone, offering significant supply chain and purity advantages for manufacturers.
Patent CN1163472C details a novel one-pot resolution of racemic hydantoin for high-purity chiral amino acids, offering significant cost and supply chain advantages.
Patent CN104232730A details enzymatic resolution for high-purity intermediates. Achieve significant cost reduction and supply chain reliability in pharmaceutical manufacturing.
Patent CN1442407A details a cost-effective resolution method for fexofenadine intermediates, ensuring high purity and scalable supply chain reliability for global pharmaceutical partners.
Patent CN101302543A reveals a microbial method for high-purity (S)-phenylethylene glycol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel enzymatic dynamic kinetic resolution for high-purity (R)-praziquantel. Reduces cost and improves supply chain reliability for API manufacturing.
Novel CvFAP mutant enables high-purity L-glufosinate synthesis via blue light catalysis, offering significant cost and supply chain advantages for herbicide manufacturers.
Patent CN115058406A reveals a novel esterase mutant for cosolvent-free l-menthol production. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturers.
Patent CN109504634A reveals enzymatic resolution for high-purity agrochemical intermediates. Achieve superior enantiomeric excess with reduced environmental impact and scalable production.